Don't miss SGLT Tools - PowerPoint slide library for SGLT2 inhibitors

Ask the Experts

  1. TxDoc
  2. Renal Transplantation
  3. Tuesday, 13 February 2018
  4.  Subscribe via email
We transplanted a kidney from a deceased donor last week. The kidney was slow to recover in one of the recipients (we received both kidneys) and that recipient was biopsied. The pathology showed renal phospholipidosis. Our pathologist was wondering about Fabry disease. I suppose we could do genetic testing on the renal biopsy. The donor had no known Fabry. But suppose the donor was a mosaic, would the kidney be at risk from low alpha-gal activity? I’m assuming the kidney will recover from the ATN, but would there be a role for enzyme replacement afterwards if the kidney does have Fabry phenotype?
Responses (2)
Accepted Answer Pending Moderation
This is a great info for all of us.
  1. more than a month ago
  2. Renal Transplantation
  3. # 1
  • Page :
  • 1

There are no replies made for this post yet.
Be one of the first to reply to this post!
Submit Your Response
Upload files or images for this discussion by clicking on the upload button below. Supports gif,jpg,png,zip,rar,pdf,jpeg,doc,docx,xls,xlsx
• Insert • Remove Upload Files (Maximum File Size: 10 MB) - NB: PLEASE REMOVE ALL IDENTIFYING DATA